Vancomycin HCl IV Injection Recalled Due to Sterility Assurance Concerns
Edge Pharma is recalling Vancomycin HCl in 0.9% Sodium Chloride Injection due to lack of assurance of sterility. The recall affects approximately 749 bags distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of an injectable drug. Lack of sterility assurance in a preservative-free intravenous medication presents a significant risk of serious infection in vulnerable patients, meeting the criterion for Severe severity.
Plain-English summary
Edge Pharma, LLC is recalling Vancomycin HCl in 0.9% Sodium Chloride Injection, USP, 1,750mg/500mL, Single Use Bag for IV Injection (Preservative Free), 500 mL pre-filled bags due to lack of assurance of sterility. The affected product is manufactured by Edge Pharma, LLC, located at 856 Hercules Dr., Colchester, VT 05446, with NDC 05446-1459-01.
Approximately 749 bags are subject to this recall. The affected product lots are 09-2021-09@6 with expiration date 12/23/2021 and 10-2021-13@5 with expiration date 01/27/2022. The product was distributed nationwide.
Vancomycin is an intravenous antibiotic used to treat serious bacterial infections. Compromised sterility in an injectable medication could result in serious infection if administered to patients. Patients who have received this product should consult their healthcare provider. Healthcare providers and patients in possession of affected product should not use it and should contact their pharmacy or healthcare facility for proper handling and disposal.
The recalled product
- Product
- Vancomycin HCl in 0.9% Sodium Chloride Injection, USP, 1,750mg/500mL, Single Use Bag for IV Injection (Preservative Free), 500 mL pre-filled bag, Rx Only, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446 NDC 05446-1459-01
- Manufacturer
- Edge Pharma, LLC
- Category
- Drug — Intravenous Injection
- Affected units
- 749
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 09-2021-09@6 12/23/2021 & 10-2021-13@5 01/27/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 56 recalled by Edge Pharma, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 56 products in this recall →Related recalls
Same manufacturer · Edge Pharma, LLC
See all →- ModerateProfound-PE Dental Gel Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-02
- SevereMVASI Sterile Ophthalmic Solution Lacks Assured Sterility
FDA (Drugs) · 2022-02-02
- ModerateLET Topical Gel drug recall for CGMP deviations
FDA (Drugs) · 2022-02-02
- SevereVancomycin HCl Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2022-02-02
- ModerateCSF-HC Otic Powder Drug Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-02
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15